People should go and have a look at the copy of the AGM and in particular page 15.."Project Development Value curve",
I would much prefer to see FMS go to production as that is where the maximum value for shareholders is.
The derisked value rang of FMS SP is potentially between 49 cents to 1.73. This is based on FMS'S own internal modelling and various infrastructure solutions.
So why did management except 30 cents a share when their own derisked value starting point is 49 cents a share, that just doesnt make sense..
Per the AGM presentation in Nov 2011
Significant valuation upside exists
• Derisking the project is the key focus of the Strategic review
• Key opportunities to derisk the project include:
? Securing access to infrastructure
? Construction of a rail spur to existing and planned rail projects
? Construction of a direct rail line to port
? Securing offtake and/or funding agreements
? Corporate level investments
? Project sale - this obviously has not provided significant valuation upside if chosen to accept only 30cents a share
- Forums
- ASX - By Stock
- RHK
- flinders mines takeover blocked
flinders mines takeover blocked, page-114
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RHK (ASX) to my watchlist
(20min delay)
|
|||||
Last
81.0¢ |
Change
0.030(3.85%) |
Mkt cap ! $161.8M |
Open | High | Low | Value | Volume |
81.0¢ | 81.0¢ | 81.0¢ | $1.62K | 2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3611 | 80.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
84.5¢ | 250 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3611 | 0.800 |
1 | 5063 | 0.790 |
2 | 7339 | 0.780 |
1 | 5000 | 0.670 |
1 | 10000 | 0.650 |
Price($) | Vol. | No. |
---|---|---|
0.845 | 250 | 1 |
0.850 | 20000 | 2 |
0.860 | 48332 | 3 |
0.870 | 10000 | 1 |
0.890 | 2368 | 1 |
Last trade - 12.39pm 10/10/2024 (20 minute delay) ? |
Featured News
RHK (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online